Hn Cure Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 25.37%
- Profit Growth 288.21%
- Ebitda 848.38%
- Net Worth 216.38%
- Total Assets -35.99%
About Hn Cure Pharma
Hn Cure Pharma Private Limited (HCPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 August 2018 (Six years and five months 11 days old ). Its registered office is in East Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ankur Varshney and Khushbu Varshney serve as directors at the Company.
Company Details
-
Location
East Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909DL2018PTC337895
-
Company No.
337895
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Aug 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Hn Cure Pharma Private Limited offer?
Hn Cure Pharma Private Limited offers a wide range of products and services, including Health Conditions, Mental Wellness.
Who are the key members and board of directors at Hn Cure Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankur Varshney
|
Director | 28-Aug-2018 | Current |
|
Khushbu Varshney
|
Director | 28-Aug-2018 | Current |
Financial Performance of Hn Cure Pharma.
Hn Cure Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.37% increase. The company also saw a substantial improvement in profitability, with a 288.21% increase in profit. The company's net worth Soared by an impressive increase of 216.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hn Cure Pharma?
Unlock access to Hn Cure Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hn Cure Pharma?
Unlock and access historical data on people associated with Hn Cure Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hn Cure Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hn Cure Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.